Clinical Trial Update: Dialogue Aimed at Reducing Anxiety in Patients With Severe COPD [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a dialogue-based intervention to reduce anxiety in patients with severe chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Nordsjaellands Hospital | Conditions: Chronic Obstructive Pulmonary Disease, Anxiety | Phase 4 | Status: COMPLETED